Network origin in Nermeen Varawalla first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Malaria Consortium
 Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson.
15
| Non-Profit Organization | Medical/Nursing Services | 15 |
| Public Company | Pharmaceuticals: Major | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Nermeen Varawalla via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Basel | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of Bocconi | College/University | Masters Business Admin | |
Baobab Circle Ltd.
 Baobab Circle Ltd. Packaged SoftwareTechnology Services Baobab Circle Ltd. develops artificial intelligence based mobile application to manage diabetes and hypertension. It offers Afya Pap has a wide range of useful functionality to help users to tackle their condition. The company was founded by Precious Lunga and George Franklin on May 31, 2013 and is headquartered in London, the United Kingdom. | Packaged Software | Founder | |
| Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | Corporate Officer/Principal | ||
| Erasmus University Rotterdam | College/University | Graduate Degree | |
Bristol-Myers Squibb World Wide Medicines Group
 Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The company is based in Lawrenceville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Bristol-Myers Squibb OOO | Chief Executive Officer | ||
| Bristol-Myers Squibb Ilaçlari, Inc. | Chief Executive Officer | ||
| Organon Central East GmbH (Hanoi City Representative Office) | Corporate Officer/Principal | ||
| Università degli Studi di Napoli Federico II | College/University | Graduate Degree | |
NovoCure GmbH
 NovoCure GmbH Pharmaceuticals: MajorHealth Technology Part of NovoCure Ltd., NovoCure GmbH is a German company that is pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. The company is based in Munich, Germany. The CEOs of the company are Asaf Danziger, Wilhelmus C. M. Groenhuysen. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Universitätsspital Basel
 Universitätsspital Basel Hospital/Nursing ManagementHealth Services Universitätsspital Basel provides medical services. It offers medical facilities for the welfare, safety and recovery of patients. The company is headquartered in Basel, Switzerland. | Hospital/Nursing Management | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| ACCELERON PHARMA INC. | Biotechnology | Corporate Officer/Principal | |
Covis Pharma Holdings BV
 Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chief Operating Officer | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| New Mexico State University | College/University | Undergraduate Degree | |
| Brown University | College/University | Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin | |
| Harvard Mit Health Sciences & Technology | College/University | Graduate Degree | |
Foundation for Innovative New Diagnostics
 Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | Director/Board Member | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal | |
| The Hebrew University of Jerusalem | College/University | Graduate Degree | |
| University of Helsinki | College/University | Doctorate Degree | |
| Aalto University School of Business | College/University | Masters Business Admin | |
| SAVARA INC. | Pharmaceuticals: Major | President | |
Leiras
 Leiras Pharmaceuticals: OtherHealth Technology Part of Bayer AG, Leiras is a Finnish company that specializes in medicinal chemicals and botanical products. The company is located in Finland. Leiras was acquired by Bayer Schering Pharma AG on July 01, 1996 for $262.11 million. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Mirror Biologics Inc
 Mirror Biologics Inc BiotechnologyHealth Technology Mirror Biologics Inc manufactures immune modulatory vaccines and therapeutics. The company is based in Tampa, FL. The company was founded in 2019 by Michael Har-Noy. Michael Har-Noy has been the CEO since 2019. | Biotechnology | Director/Board Member | |
International Vaccine Institute
 International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Miscellaneous Commercial Services | Director/Board Member | |
Anergis SA
 Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| University of London | College/University | Graduate Degree | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
Les Laboratoires Servier SAS
 Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EUROPEAN MEDICAL SOLUTIONS | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Dellmed Consulting | Founder | ||
| Université Paris-Saclay | College/University | Doctorate Degree | |
Drugs for Neglected Diseases initiative
 Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Biotechnology | Director/Board Member | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
| United States | 15 |
| Switzerland | 9 |
| France | 5 |
| Finland | 5 |
| Germany | 4 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 17 |
| Health Services | 3 |
| Technology Services | 2 |
| Commercial Services | 2 |
Operational
| Corporate Officer/Principal | 23 |
| Director/Board Member | 21 |
| Chief Executive Officer | 8 |
| Graduate Degree | 5 |
| Chief Operating Officer | 4 |
Most connected contacts
- Stock Market
- Insiders
- Nermeen Varawalla
- Company connections
